News Israel today

latest news from Israel in english

Mitsubishi Tanabe buys Israeli company for $1.1 billion

Japanese Corporation Mitsubishi Tanabe Pharma announced the acquisition of the Neuroderm, an Israeli company engaged in the development of new methods of treatment of diseases of the Central nervous system.

The transaction value should reach $ 1.1 billion, which is 15% above the cost of shares in Israeli companies on wall Street.

Company’s leading product – an apparatus for administering the medication Carbidopa Levodopa for the treatment of symptoms in advanced stage Parkinson’s disease.

The company has issued its shares on the stock exchange of high technologies NASDAQ in 2014, and was valued by investors at 164 million dollars.

Mitsubishi Tanabe buys Israeli company for $1.1 billion 24.07.2017

Поделиться в соц. сетях

Опубликовать в Google Buzz
Опубликовать в Google Plus
Опубликовать в LiveJournal
Опубликовать в Мой Мир
Опубликовать в Одноклассники
Latest news from Israel in english © 2010-2015
38 queries